You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CMML

Showing 1 - 25 of 200
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023

MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023

Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)

Not yet recruiting
  • Hematologic Malignancy
  • BC3402 Injection
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Jinan University
Jan 10, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Nov 29, 2022

MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Aachen, NRW, Germany
  • +2 more
Mar 29, 2023

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

Recruiting
  • AML
  • +6 more
  • Gilbert, Arizona
  • +7 more
Jul 8, 2022

Myelomonocytic Leukemia Trial in United States (Ruxolitinib)

Completed
Has Results
  • Myelomonocytic Leukemia
  • Tampa, Florida
  • +5 more
Sep 9, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,

Terminated
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
Apr 4, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

AML/MDS, CMML, Relapse Trial in China, Spain, United States (LP-108, LP-108 and azacitidine)

Recruiting
  • AML/MDS
  • +5 more
  • Ann Arbor, Michigan
  • +7 more
Feb 14, 2022

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS, Chronic Myelomonocytic Leukemia (CMML) Trial (SNS-301)

Withdrawn
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia (CMML)
  • (no location specified)
Aug 9, 2021

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

AML, Adult Trial in Australia, China, United States (APG 2575 ramp up arm)

Recruiting
  • AML, Adult
  • APG 2575 ramp up arm
  • Baltimore, Maryland
  • +6 more
Aug 12, 2022

Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML) Trial in Italy (NMS-03592088)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Bergamo, BG, Italy
  • +4 more
Mar 23, 2021

Chronic Myeloid Leukemia Trial in France (Venetoclax)

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Amiens, France
  • +14 more
Mar 3, 2023

Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

Recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Chronic Myelomonocytic Leukemia Trial

Recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2022